Epidemiological and clinical characteristics of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare workers in Hubei Province, China

被引:6
|
作者
Wu, Mingyang [1 ]
Xie, Cong [2 ]
Wu, Ran [2 ]
Shu, Yanling [3 ]
Wang, Lulin [1 ]
Li, Mingyan [2 ]
Wang, Youjie [1 ]
机构
[1] Huazhong Univ Sci & Technol, Sch Publ Hlth, Dept Maternal & Child Hlth, Tongji Med Coll, Wuhan, Hubei, Peoples R China
[2] Hubei Prov Ctr Dis Control & Prevent, Inst Prevent Med Informat, Wuhan, Hubei, Peoples R China
[3] Huazhong Univ Sci & Technol, Wuhan Childrens Hosp, Tongji Med Coll, Dept Lab Med, Wuhan, Hubei, Peoples R China
来源
关键词
COVID-19; SARS;
D O I
10.1017/ice.2020.1321
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To evaluate the epidemiological and clinical characteristics of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare workers (HCWs) in Hubei Province, China. Design: Retrospective cohort study. Setting: Hubei Provincial Center for Disease Control and Prevention. Participants: The participants in this study are cases identified by epidemiological investigation in Hubei Province, as of February 27, 2020, and were followed until March 7, 2020. In total, 1,989 HCWs and 41,137 other occupational cases were included for analysis. Methods: We used descriptive statistics to summarize patient characteristics. Results: Of 1,989 laboratory-confirmed HCWs, 297 (14.93%) had severe or critical cases, 73 (3.67%) had asymptomatic infections, and 18 died of coronavirus disease 2019 (COVID-19). The case fatality rate was 0.9%. The proportion of severe or critical cases decreased from the beginning to the end of the outbreak (from 21.29% to 3.52%), and the proportion of asymptomatic cases increased from 0.0% to 47.18%. Nearly half of HCWs with confirmed COVID-19 reported no known contact with COVID-19 patients (969, 48.72%). Fever and cough were the most common symptoms at disease onset in both HCWs and other occupational cases; however, HCWs had higher rates of fatigue (30.90% vs 25.02%; P < .001) and myalgia (19.15% vs 13.43%; P < .001). Additionally, compared with other occupational groups, HCWs were associated with a lower risk of death after adjustment for potential confounders (odd ratio [OR], 0.50; 95% confidence interval [CI], 0.30-0.79). Conclusions: Compared with COVID-19 cases in other occupational groups, HCWs with COVID-19 have half the risk of death, although they have been shown to have higher rates of fatigue and myalgia.
引用
收藏
页码:924 / 930
页数:7
相关论文
共 50 条
  • [41] Implications of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on the Epidemiology of Pediatric Respiratory Syncytial Virus Infection
    Odumade, Oludare A.
    van Haren, Simon D.
    Angelidou, Asimenia
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (SUPPL 1) : S130 - S135
  • [42] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review
    Wei Feng
    Wei Zong
    Feng Wang
    Shaoqing Ju
    Molecular Cancer, 19
  • [43] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review
    Feng, Wei
    Zong, Wei
    Wang, Feng
    Ju, Shaoqing
    MOLECULAR CANCER, 2020, 19 (01)
  • [44] Clinical characteristics of acute respiratory syndrome with SARS-CoV-2 infection in children in South China
    Zheng, Guilang
    Wang, Bangqin
    Zhang, Hua
    Xie, Chuxing
    Zhang, Yuehua
    Wen, Zhihong
    Guo, Qingyun
    Zhu, Hong
    Ye, Guojing
    Liang, Jiayi
    Meng, Qiong
    Xie, Jingquan
    Jiang, Suhua
    Liu, Guojun
    Gao, Wenjun
    Wang, Yanhao
    Guo, Yuxiong
    PEDIATRIC PULMONOLOGY, 2020, 55 (09) : 2419 - 2426
  • [45] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in vaccinated and unvaccinated healthcare personnel in a Veterans' Affairs healthcare system
    Redmond, Sarah N.
    Jones, Lucas D.
    Sadri, Navid
    Schmotzer, Christine
    Navas, Maria E.
    Zabarsky, Trina F.
    Bhullar, Davinder
    Donskey, Curtis J.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2022, 43 (09): : 1300 - 1301
  • [46] The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers
    Lumley, Sheila F.
    Wei, Jia
    O'Donnell, Denise
    Stoesser, Nicole E.
    Matthews, Philippa C.
    Howarth, Alison
    Hatch, Stephanie B.
    Marsden, Brian D.
    Cox, Stuart
    James, Tim
    Peck, Liam J.
    Ritter, Thomas G.
    de Toledo, Zoe
    Cornall, Richard J.
    Jones, E. Yvonne
    Stuart, David, I
    Screaton, Gavin
    Ebner, Daniel
    Hoosdally, Sarah
    Crook, Derrick W.
    Conlon, Christopher P.
    Pouwels, Koen B.
    Walker, A. Sarah
    Peto, Tim E. A.
    Walker, Timothy M.
    Jeffery, Katie
    Eyre, David W.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (03) : E699 - E709
  • [47] Persistent infection with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in a patient with untreated human immunodeficiency virus (HIV)
    Zhabokritsky, Alice
    Mubareka, Samira
    Kozak, Robert A.
    Maguire, Finlay
    Yip, Lily
    Yip, Paul
    Powis, Jeff
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2023, 44 (02) : 350 - 351
  • [48] Risk and protective factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare workers: A test-negative case-control study in Quebec, Canada
    Carazo, Sara
    Villeneuve, Jasmin
    Laliberte, Denis
    Longtin, Yves
    Talbot, Denis
    Martin, Richard
    Denis, Geoffroy
    Ducharme, Francine
    Paquet-Bolduc, Bianka
    Anctil, Genevieve
    Hegg-Deloye, Sandrine
    De Serres, Gaston
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2023, 44 (07) : 1121 - 1130
  • [49] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated
    Wambier, Carlos Gustavo
    Goren, Andy
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : 308 - 309
  • [50] The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
    Mirzaei, Rasoul
    Mahdavi, Farzad
    Badrzadeh, Fariba
    Hosseini-Fard, Seyed Reza
    Heidary, Maryam
    Jeda, Ali Salimi
    Mohammadi, Tayeb
    Roshani, Mahdane
    Yousefimashouf, Rasoul
    Keyvani, Hossein
    Darvishmotevalli, Mohammad
    Sani, Melika Zarei
    Karampoor, Sajad
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 90